Great Eccleston Medical Supplies Limited - Period Ending 2023-07-31

Great Eccleston Medical Supplies Limited - Period Ending 2023-07-31


Great Eccleston Medical Supplies Limited 03331442 false 2022-08-01 2023-07-31 2023-07-31 The principal activity of the company is that of pharmacutical supplies. Digita Accounts Production Advanced 6.30.9574.0 true true 03331442 2022-08-01 2023-07-31 03331442 2023-07-31 03331442 core:CurrentFinancialInstruments 2023-07-31 03331442 core:CurrentFinancialInstruments core:WithinOneYear 2023-07-31 03331442 core:FurnitureFittingsToolsEquipment 2023-07-31 03331442 core:MotorVehicles 2023-07-31 03331442 core:OtherPropertyPlantEquipment 2023-07-31 03331442 bus:SmallEntities 2022-08-01 2023-07-31 03331442 bus:AuditExemptWithAccountantsReport 2022-08-01 2023-07-31 03331442 bus:FullAccounts 2022-08-01 2023-07-31 03331442 bus:SmallCompaniesRegimeForAccounts 2022-08-01 2023-07-31 03331442 bus:RegisteredOffice 2022-08-01 2023-07-31 03331442 bus:Director1 2022-08-01 2023-07-31 03331442 bus:Director2 2022-08-01 2023-07-31 03331442 bus:Director3 2022-08-01 2023-07-31 03331442 bus:PrivateLimitedCompanyLtd 2022-08-01 2023-07-31 03331442 core:FurnitureFittings 2022-08-01 2023-07-31 03331442 core:FurnitureFittingsToolsEquipment 2022-08-01 2023-07-31 03331442 core:MotorVehicles 2022-08-01 2023-07-31 03331442 core:OtherPropertyPlantEquipment 2022-08-01 2023-07-31 03331442 core:PlantMachinery 2022-08-01 2023-07-31 03331442 countries:UnitedKingdom 2022-08-01 2023-07-31 03331442 2022-07-31 03331442 core:FurnitureFittingsToolsEquipment 2022-07-31 03331442 core:MotorVehicles 2022-07-31 03331442 core:OtherPropertyPlantEquipment 2022-07-31 03331442 2021-08-01 2022-07-31 03331442 2022-07-31 03331442 core:CurrentFinancialInstruments 2022-07-31 03331442 core:CurrentFinancialInstruments core:WithinOneYear 2022-07-31 03331442 core:FurnitureFittingsToolsEquipment 2022-07-31 03331442 core:MotorVehicles 2022-07-31 03331442 core:OtherPropertyPlantEquipment 2022-07-31 iso4217:GBP xbrli:pure

Registration number: 03331442

Great Eccleston Medical Supplies Limited

Unaudited Filleted Financial Statements

for the Year Ended 31 July 2023

 

Great Eccleston Medical Supplies Limited

Contents

Company Information

1

Balance Sheet

2 to 3

Notes to the Unaudited Financial Statements

4 to 8

 

Great Eccleston Medical Supplies Limited

Company Information

Directors

Mr Imraan Khan

Mr David Ashton

Mr Philip Ashton

Registered office

Farley Chemist 59
Higher Parr Street
St. Helens
WA9 1AD

Accountants

EKWilliams Accountants Limited
1 Pavilion Square
Westhoughton
Bolton
BL5 3AJ

 

Great Eccleston Medical Supplies Limited

(Registration number: 03331442)
Balance Sheet as at 31 July 2023

Note

2023
£

2022
£

Fixed assets

 

Tangible assets

4

77,518

1,161

Current assets

 

Stocks

5

37,177

33,279

Debtors

6

25,066

546,758

Cash at bank and in hand

 

323,832

259,189

 

386,075

839,226

Creditors: Amounts falling due within one year

7

(426,474)

(284,090)

Net current (liabilities)/assets

 

(40,399)

555,136

Total assets less current liabilities

 

37,119

556,297

Provisions for liabilities

(19,379)

(220)

Net assets

 

17,740

556,077

Capital and reserves

 

Called up share capital

436

436

Retained earnings

17,304

555,641

Shareholders' funds

 

17,740

556,077

For the financial year ending 31 July 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

 

Great Eccleston Medical Supplies Limited

(Registration number: 03331442)
Balance Sheet as at 31 July 2023

Approved and authorised by the Board on 22 March 2024 and signed on its behalf by:
 

.........................................
Mr Imraan Khan
Director

 

Great Eccleston Medical Supplies Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 July 2023

1

General information

The company is a private company limited by share capital, incorporated in United Kingdom.

The address of its registered office is:
Farley Chemist 59
Higher Parr Street
St. Helens
WA9 1AD
England

These financial statements were authorised for issue by the Board on 22 March 2024.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Going concern

The financial statements have been prepared on a going concern basis.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

 

Great Eccleston Medical Supplies Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 July 2023

Deferred tax is recognised in respect of all timing differences between taxable profits and profits reported in the financial statements.

Unrelieved tax losses and other deferred tax assets are recognised when it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Fixtures & Fittings

15% on Reducing Balance

Motor Vehicles

25% on Reducing Balance

Plant & Machinery

15% on Reducing Balance

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.

The cost of finished goods and work in progress comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the inventories to their present location and condition. At each reporting date, stocks are assessed for impairment. If stocks are impaired, the carrying amount is reduced to its selling price less costs to complete and sell; the impairment loss is recognised immediately in profit or loss.

 

Great Eccleston Medical Supplies Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 July 2023

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 14 (2022 - 14).

 

Great Eccleston Medical Supplies Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 July 2023

4

Tangible assets

Furniture, fittings and equipment
 £

Motor vehicles
 £

Other tangible assets
£

Total
£

Cost or valuation

At 1 August 2022

6,955

8,500

4,090

19,545

Additions

1,202

100,761

-

101,963

At 31 July 2023

8,157

109,261

4,090

121,508

Depreciation

At 1 August 2022

6,655

7,890

3,839

18,384

Charge for the year

225

25,343

38

25,606

At 31 July 2023

6,880

33,233

3,877

43,990

Carrying amount

At 31 July 2023

1,277

76,028

213

77,518

At 31 July 2022

300

610

251

1,161

5

Stocks

2023
£

2022
£

Finished goods and goods for resale

37,177

33,279

6

Debtors

Current

Note

2023
£

2022
£

Trade debtors

 

3,038

-

Amounts owed by related parties

-

526,980

Other debtors

 

22,028

19,778

   

25,066

546,758

 

Great Eccleston Medical Supplies Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 July 2023

7

Creditors

Creditors: amounts falling due within one year

2023
£

2022
£

Due within one year

Trade creditors

385,993

259,548

Taxation and social security

21,805

20,574

Accruals and deferred income

1,550

1,550

Other creditors

17,126

2,418

426,474

284,090

A debenture has been lodged at Companies House, in favour of Santander bank, with fixed and floating charges over all assets, dated 2 August 2021